Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

    Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan
    e2011060
    2011-12-07
    https://doi.org/10.4084/mjhid.2011.060
    3010
    PDF: 940
    HTML: 2288
  • SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA

    Seung Beom Han, Hye Jo Shin, Eui Soo Lee, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Jin Han Kang
    e2019052
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.052
    1147
    PDF: 786
    HTML: 187
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1374
    PDF: 662
    HTML: 242
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1087
    PDF: 539
    HTML: 1689
    Figures: 165
    Fifures Sanz: 176
    tables Sanz: 180
    Untitled: 176
  • INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

    Livio Pagano, Davide Facchinelli, Dr.
    e2018063
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.063
    2024
    PDF: 1111
    HTML: 179
  • DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML

    Istemi SERIN, Mustafa PEHLIVAN, Kursat OZDILLI, Fatma OGUZ SAVRAN, Gaye TOMATIR, Sacide PEHLIVAN
    e2021020
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.020
    1079
    PDF: 420
    HTML: 239
  • A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

    Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini
    e2017046
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.046
    2638
    PDF: 993
    HTML: 1106
  • Pulmonary actinomycosis by Actinomyces graevenitzii in two hematologic patients.

    GABRIELE FACCHIN, Giulia Battaglia, Assunta Sartor, Carla Filì, Maria Elena Zannier, Marta Lisa Battista, Renato Fanin, Anna Candoni
    e2023034
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.034
    955
    PDF: 759
    HTML: 396
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    1811
    PDF: 979
    HTML: 630
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1886
    PDF: 1007
    HTML: 1336
  • Defining invasive fungal infection risk in hematological malignancies: a new tool for clinical practice

    Benedetta Rambaldi, Domenico Russo, Livio Pagano
    e2017012
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.012
    2634
    PDF: 1197
    HTML: 1563
  • PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2014029
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.029
    1329
    PDF: 781
    HTML: 2257
  • CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

    omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad
    e2015049
    2015-08-25
    https://doi.org/10.4084/mjhid.2015.049
    1542
    PDF: 877
    HTML: 976
    figures: 177
    table 1: 180
    table2: 179
    table3: 180
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2163
    PDF: 1469
    HTML: 262
  • DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse

    xinchen fang, Zimin Sun, Huilan Liu, Xiang Wan, Wen Yao, Kaidi Song, Kaidi Song, Baolin Tang, Xiaoyu zhu, Jun Peng
    e2021005
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.005
    1352
    PDF: 525
    HTML: 195
  • CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Rafael de la Camara
    e2016031
    2016-06-20
    https://doi.org/10.4084/mjhid.2016.031
    4776
    PDF: 1761
    HTML: 2704
    Untitled: 213
  • OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.

    Shuvra Neel Baul, Rajib De, PRAKAS KUMAR MANDAL, Swagnik Roy, Tuphan Kanti Dolai, Prantar Chakrabarti
    e2018051
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.051
    2171
    PDF: 923
    HTML: 407
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 211
    UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 339
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 237
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 256
  • IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti
    e2016057
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.057
    4313
    PDF: 1098
    HTML: 1414
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    781
    PDF: 514
    HTML: 78
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1000
    PDF: 720
    HTML: 83
  • SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

    Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil
    e2021006
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.006
    2021
    PDF: 818
    HTML: 208
  • ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

    Soner Solmaz
    e2016019
    2016-03-01
    https://doi.org/10.4084/mjhid.2016.019
    3010
    PDF: 958
    HTML: 1565
  • Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

    Zhan Su, Feng Wang
    e2025063
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.063
    866
    PDF: 471
    HTML: 123
    Suppl. Files: 308
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1213
    PDF: 460
    HTML: 152
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    2839
    PDF: 1034
    HTML: 303
  • "ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"

    Benedetto Bruno, Luisa Giaccone, Moreno Festuccia, Mario Boccadoro
    e2010013
    2010-06-01
    https://doi.org/10.4084/mjhid.2010.013
    1399
    PDF: 658
    HTML: 1506
  • ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

    Alessandro Busca, Livio Pagano
    e2016039
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.039
    4712
    PDF: 1548
    HTML: 2251
    Untitled: 205
    Untitled: 221
    Untitled: 228
    Untitled: 211
    Untitled: 213
  • COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

    Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast
    e2022032
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.032
    988
    PDF: 531
    HTML: 204
  • Isavuconazole successfully treated pulmonary mucormycosis in acute myeloid leukemia: A case report

    Hong Chen, Kun Chen, wenqiang kong
    e2025031
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.031
    833
    PDF: 728
    HTML: 80
  • THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

    Pau Montesinos, Miguel A Sanz
    e2011059
    2011-12-04
    https://doi.org/10.4084/mjhid.2011.059
    3048
    PDF: 1520
    HTML: 2440
  • ANTIBIOTIC LOCK THERAPY FOR PORT CATHETER-RELATED INFECTIONS OF CHILDREN WITH ACUTE LEUKEMIA

    Burçin Kurtipek; Ayça Koca Yozgat, Saliha Kanık Yüksek, Dilek Kaçar, Turan Bayhan, Dilek Gürlek Gökçebay, Aslınur Özkaya Parlak, Neşe Yaralı
    e2024072
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.072
    1879
    PDF: 945
    HTML: 274
  • Bacillus cereus in the neutropenic patient: case report in a patient with myelodysplastic syndrome and review of the literature

    Mariam Markouli, Sevastianos Chatzidavid, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Amalia Anastasopoulou, Nora-Athina Viniou, Panagiotis Diamantopoulos
    e2022071
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.071
    926
    PDF: 746
    HTML: 197
  • Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib

    Fahir Ozturk, Mehmet Sezgin Pepeler, Esra Ucaryilmaz Ozhamam, Gulten Korkmaz
    e2025020
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.020
    918
    PDF: 880
    HTML: 80
  • High Tuberculosis density incidence rate in Matched Unrelated Allogeneic stem cell transplantation recipients in the state of São Paulo, Brazil

    Marcelo Nóbrega Litvoc, silvia F costa, Fabio Eudes Leal, Diogo Boldim Ferreira, Max Igor Banks Ferreira Lopes, Ligia Capuani, Vanderson Geraldo Rocha
    e2023037
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.037
    601
    PDF: 837
    Suppl. Files: 85
    HTML: 222
  • BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE

    Michele Malagola
    e2017036
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.036
    2389
    PDF: 808
    HTML: 1057
  • THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

    adel abd elhaleim hagag
    e2013065
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.065
    2589
    PDF: 827
    HTML: 14944
    Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 301
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1665
    PDF: 720
    HTML: 2914
  • PROTECTIVE ROLE OF SYLIMARIN ON METHOTREXATE INDUCED HEPATO-NEPHROTOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2016043
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.043
    3583
    PDF: 1026
    HTML: 1289
  • Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

    Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain
    e2010012
    2010-05-31
    https://doi.org/10.4084/mjhid.2010.012
    1057
    PDF: 686
    HTML: 345
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2491
    PDF: 1980
    HTML: 199
  • IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

    Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani
    e2014042
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.042
    2102
    PDF: 1142
    HTML: 1991
  • COINCIDENCE OR CONNECTION? REVISITING THE RELATIONSHIP BETWEEN MASTOCYTOSIS AND LYMPHOMA

    Antonio Frolli, Cristina Papayannidis, Carmen Fava, Martina Bullo, Selene Grano, Valentina Bonuomo, Daniela Gottardi, Guido Parvis, Beatrice Casadei, Daniela Cilloni
    e2026047
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.047
    138
    PDF: 154
    HTML: 9
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2527
    PDF: 866
    HTML: 2120
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2775
    PDF: 762
    HTML: 1266
    Blood Count trend before and during lenalidomide treatment: 170
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 187
  • CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

    Edoardo Olivari
    e2025079
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.079
    422
    PDF: 207
    Html: 57
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    1975
    PDF: 1118
    HTML: 614
  • A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

    Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani
    e2012017
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.017
    1165
    PDF: 655
    HTML: 747
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN

    Ramzi Jeddi, Hèla Ghédira, Ramzi Ben Amor, Yosr Ben Abdennebi, Kacem Karima, Zarrouk Mohamed, Hend Ben Neji, Lamia Aissaoui, Raihane Ben Lakhal, Naouel Ben Salah, Samia Menif, Zaher Belhadjali, Hela Ben Abid, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb
    e2011033
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.033
    3865
    PDF: 750
    HTML: 1846
  • EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever

    Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali
    e2022039
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.039
    1444
    PDF: 1049
    HTML: 213
  • COMPARISON OF PRESEPSIN, PROCALCITONIN, INTERLEUKIN-8 AND C-REACTIVE PROTEIN IN PREDICTING BACTERAEMIA IN FEBRILE NEUTROPENIC ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

    Irena Kostic, Carmela Gurrieri, Elisa Piva, Gianpietro Semenzato, Mario Plebani, Ilaria Caputo, Fabrizio Vianello
    e2019047
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.047
    1540
    PDF: 1247
    HTML: 234
151 - 200 of 206 items << < 1 2 3 4 5 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy